Magnetic Resonance Spectroscopy. Tools for Neuroscience Research and Emerging Clinical Applications

Content: 
Front-matter, Pages i,iii
Copyright, Page iv
Acknowledgements, Page ix
Contributors, Pages xi-xii, Prasanth Ariyannur, Peethambaran Arun, Carles Arús, Ian C. Atkinson, Velicia Bachtiar, Kevin L. Behar, Jonathan G. Best, Andrew Bivard, Vincent O. Boer, Jennifer Brawn, Dallas Card, Kim C. Cecil, Olga Ciccarelli, Henk M. De Feyter, Robin A. de Graaf, Nicola De Stefano, Andrea Dennis, Nicholas Gant, Antonio Giorgio, Rolf Gruetter,  et al.
Introduction, Pages xiii-xvi
Chapter 1.1 - Basis of Magnetic Resonance, Pages 3-14, Christoph Juchem, Douglas L. Rothman
Chapter 1.2 - Localized Single-Voxel Magnetic Resonance Spectroscopy, Water Suppression, and Novel Approaches for Ultrashort Echo-Time Measurements, Pages 15-30, Hongxia Lei, Lijing Xin, Rolf Gruetter, Vladimír Mlynárik
Chapter 1.3 - Technical Considerations for Multivoxel Approaches and Magnetic Resonance Spectroscopic Imaging, Pages 31-39, Vincent O. Boer, Dennis W.J. Klomp
Chapter 1.4 - Spectral Editing and 2D NMR, Pages 40-48, Robin A. de Graaf
Chapter 1.5 - Spectral Quantification and Pitfalls in Interpreting Magnetic Resonance Spectroscopic Data: What To Look Out For, Pages 49-67, Jamie Near
Chapter 2.1 - N-Acetylaspartate and N-Acetylaspartylglutamate in Central Nervous System Health and Disease, Pages 71-90, John R. Moffett, Prasanth Ariyannur, Peethambaran Arun, Aryan M.A. Namboodiri
Chapter 2.2 - The Biochemistry of Creatine, Pages 91-103, Clare E. Turner, Nicholas Gant
Chapter 2.3 - The Biochemistry of Choline, Pages 104-110, Joanne C. Lin, Nicholas Gant
Chapter 2.4 - Glutamate, Pages 111-121, Jun Shen
Chapter 2.5 - Other Significant Metabolites: Myo-Inositol, GABA, Glutamine, and Lactate, Pages 122-138, Jonathan G. Best, Charlotte J. Stagg, Andrea Dennis
Chapter 3.1 - Usefulness of Proton Magnetic Resonance Spectroscopy in the Clinical Management of Brain Tumors, Pages 141-161, Carles Majós, Margarida Julià-Sapé, Carles Arús
Chapter 3.2 - Multiple Sclerosis and Inflammatory Diseases, Pages 162-171, Nicola De Stefano, Antonio Giorgio
Chapter 3.3 - Epilepsy, Pages 172-182, Jullie Pan, Hoby Hetherington
Chapter 3.4 - Stroke and Cerebral Ischemia, Pages 183-195, Andrew Bivard, Peter Stanwell, Mark Parsons
Chapter 3.5 - Use of MRS in Inborn Errors of Metabolism: Canavan’s Disease and MRS in Differential Diagnosis, Pages 196-221, Kim M. Cecil
Chapter 3.6 - MRS of Psychiatric Disorders, Pages 222-228, Matthew Taylor
Chapter 3.7 - Preclinical and Clinical Applications of 1H MRS in the Spinal Cord, Pages 229-242, Amber Michelle Hill, Olga Ciccarelli
Chapter 3.8 - Interindividual Differences in Behavior and Plasticity, Pages 243-253, Velicia Bachtiar, Charlotte J. Stagg
Chapter 3.9 - MRS in Development and Across the Life Span, Pages 254-265, Dallas Card, Margot J. Taylor, John G. Sled
Chapter 3.10 - Hormonal Influences on Magnetic Resonance Spectroscopy Measures, Pages 266-273, Jennifer Brawn, Katy Vincent
Chapter 3.11 - Magnetic Resonance Spectroscopy in Neuroenergetics and Neurotransmission, Pages 274-288, Nicola R. Sibson, Kevin L. Behar
Chapter 4.1 - Quantitative Metabolic Magnetic Resonance Imaging of Sodium, Oxygen, Phosphorus and Potassium in the Human Brain: A Rationale for Bioscales in Clinical Applications, Pages 291-311, Keith R. Thulborn, Ian C. Atkinson
Chapter 4.2 - Carbon (13C) MRS, Pages 312-330, Douglas L. Rothman, Henk M. De Feyter
Chapter 4.3 - Hyperpolarized Magnetic Resonance Imaging and Spectroscopy of the Brain, Pages 331-349, Brian Ross
Index, Pages 351-359